Schering-Plough is a worldwide pharmaceutical company committed to discovering, developing and marketing new therapies and treatment programs that can improve peoples health and extend lives. The company is a recognized leader in biotechnology, genomics and gene therapy. Core product groups are allergy and respiratory, anti-infective and anti-cancer, cardiovasculars and dermatologicals
Schering-Plough LTD, Singapore Branch was the first major US pharmaceutical company to establish manufacturing operations in Singapore in 1994. With a total investment of over US$1 billion, Schering-Plough LTD is one of the largest pharmaceutical investors in Singapore. With a total of 7 manufacturing plants in Singapore, Schering-Plough LTD has one of the most diverse and ever expanding pharmaceutical manufacturing profiles in the country. We produce a wide range of pharmaceuticals including active drug substances, tablets, dry powder inhalers, sterile injectables and nasal sprays.
Our Vision - To be A Star Performer for Schering-Plough Worldwide
Our Mission To be Best in class for :
People
Value
Quality
Customer Service
Safety, Health & Environment
Our Values - We believe in :
Trust
Ownership
Partnership
Improvement
Care
Visitors since May, 2007
